Gardasil 9

Land: Norge

Språk: norsk

Kilde: Statens legemiddelverk

Aktiv ingrediens:

Humant papillomavirus, type 6 L1 protein, rekombinant / Humant papillomavirus, type 11 L1 protein, rekombinant / Humant papillomavirus, type 16 L1 protein, rekombinant / Humant papillomavirus, type 18 L1 protein, rekombinant / Humant papillomavirus, type 31 L1 protein, rekombinant / Humant papillomavirus, type 33 L1 protein, rekombinant / Humant papillomavirus, type 45 L1 protein, rekombinant / Humant papillomavirus, type 52 L1 protein, rekombinant / Humant papillomavirus, type 58 L1 protein, rekombinant

Tilgjengelig fra:

Orifarm AS

ATC-kode:

J07BM03

INN (International Name):

Humant papillomavirus, type 6 L1 protein, rekombinant / Humant papillomavirus, type 11 L1 protein, rekombinant / Humant papillomavirus, type 16 L1 protein, rekombinant / Humant papillomavirus, type 18 L1 protein, rekombinant / Humant papillomavirus, type 31 L1 protein, rekombinant / Humant papillomavirus, type 33 L1 protein, rekombinant / Humant papillomavirus, type 45 L1 protein, rekombinant / Humant papillomavirus, type 52 L1 protein, rekombinant / Humant papillomavirus, type 58 L1 protein, rekombinant

Legemiddelform:

Injeksjonsvæske, suspensjon

Enheter i pakken:

Ferdigfylt sprøyte 1x0.5 ml

Resept typen:

C

Autorisasjon status:

Markedsført

Autorisasjon dato:

2022-04-01